Actualización sobre tratamiento del edema macular diabético (Parte I)

Bibliografía:

[1] J. Bali and R. T. Bali, “Pathological ocular angiogenesis in diabetes: a perspective of emerging paradigms and current evidence,” Journal of Clinical Ophthalmology and Research, vol. 1, no. 1, pp. 3–10, 2013.
Journal of Diabetes Research 7
[2] “Photocoagulation for diabeticmacular edema. Early treatment diabetic retinopathy study report number 1. Early treatment diabetic retinopathy study group,” Archives of Ophthalmology, vol. 103, no. 12, pp. 1796–1806, 1985.
[3] D. N. Koleva-Georgieva and N. P. Sivkova, “Types of diabetic macular edema assessed by optical coherence tomography,” Folia medica, vol. 50, no. 3, pp. 30–38, 2008.
[4] S.W. Kang,C.Y.Park, andD.-I.Ham, “The correlationbetween fluorescein angiographic and optical coherence tomographic features in clinically significant diabeticmacular edema,” American Journal of Ophthalmology, vol. 137, no. 2, pp. 313–322, 2004.
[5] “Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study research group,” Ophthalmology, vol. 98, supplement, no. 5, pp. 807–822, 1991. [6] D. A. 
6) Dmuchowska, P. Krasnicki, and Z. Mariak, “Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy?” Graefe’s Archive for Clinical and Experimental Ophthalmology, vol. 252, no. 5, pp.
731–738, 2014.